|
SYAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.60039999999829E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51630999999375E-05 |
| Normal-vs-Stage2 |
3.331400E-01 |
| Normal-vs-Stage3 |
7.749000E-01 |
| Normal-vs-Stage4 |
5.481800E-01 |
| Stage1-vs-Stage2 |
3.431000E-01 |
| Stage1-vs-Stage3 |
2.724500E-02 |
| Stage1-vs-Stage4 |
2.601000E-01 |
| Stage2-vs-Stage3 |
3.531200E-01 |
| Stage2-vs-Stage4 |
9.015800E-01 |
| Stage3-vs-Stage4 |
5.287800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.49209999999556E-05 |
| Normal-vs-AfricanAmerican |
9.283800E-02 |
| Normal-vs-Asian |
6.946400E-01 |
| Caucasian-vs-AfricanAmerican |
1.628210E-01 |
| Caucasian-vs-Asian |
4.053000E-01 |
| AfricanAmerican-vs-Asian |
7.988200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.17879952863132E-10 |
| Normal-vs-Female |
7.518600E-03 |
| Male-vs-Female |
2.19035900528297E-12 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.383800E-01 |
| Normal-vs-Extreme_Weight |
9.19520000142171E-08 |
| Normal-vs-Obese |
1.890250E-02 |
| Normal-vs-Extreme_Obese |
5.337500E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.113500E-02 |
| Normal_Weight-vs-Obese |
6.558400E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.758200E-01 |
| Extreme_Weight-vs-Obese |
1.823920E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.705000E-01 |
| Obese-vs-Extreme_Obese |
5.256000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.357200E-01 |
| Normal-vs-Age(41-60Yrs) |
2.753600E-02 |
| Normal-vs-Age(61-80Yrs) |
3.9075000002331E-07 |
| Normal-vs-Age(81-100Yrs) |
1.810900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.651600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.323700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.086400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.435600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.114200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.845200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.94580000001388E-07 |
| Normal-VS-Type2 PRCC |
2.011700E-02 |
| Normal-VS-KIRP CIMP |
1.208150E-01 |
| Normal-VS-Unclassified PRCC |
5.276400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.573220E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.133680E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.218990E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.296300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.347800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.616900E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.415700E-03 |
| Normal-vs-N1 |
6.536200E-01 |
| Normal-vs-N2 |
8.403600E-01 |
| N0-vs-N1 |
5.876400E-02 |
| N0-vs-N2 |
2.207200E-01 |
| N1-vs-N2 |
9.427000E-01 |
|
|
